---
schema_version: "secwatch.filing_event.v1"
accession: "0001653477-24-000096"
form_type: "8-K"
ticker: "NGVT"
cik: "0001653477"
company_name: "Ingevity Corp"
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:17:58.571921+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ingevity Q3 net loss $107.2M; sales down 16% YoY; affirms FY adjusted EBITDA guidance

## Summary
- Net sales $376.9M, down 16% YoY, primarily due to Performance Chemicals repositioning.
- Net loss $107.2M ($2.95 diluted EPS) includes $86.9M restructuring charges and $100M contract termination fees.
- Adjusted EPS $1.10; adjusted EBITDA $106.4M (28.2% margin).
- Full-year guidance: sales $1.40-$1.50B, adjusted EBITDA $350-$360M.
- Operating cash flow $46.5M, free cash flow $28.5M.

## SEC filing metadata
- accession: 0001653477-24-000096
- form_type: 8-K
- ticker: NGVT
- cik: 0001653477
- company_name: Ingevity Corp
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1653477/000165347724000096/0001653477-24-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1653477/000165347724000096/ngvt-20241029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001653477-24-000096
- JSON: https://secwatch.observer/filing/0001653477-24-000096.json
- Plain text: https://secwatch.observer/filing/0001653477-24-000096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.